Full-SpectruM Archives - Freedom Wares

PubMed is a free, comprehensive database of scientific and medical literature, primarily focusing on biomedical and life sciences research. It is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). PubMed is one of the most widely used resources for healthcare professionals, researchers, and students to access peer-reviewed articles, clinical studies, and other scientific publications.

Canna~Fangled Abstracts

Evaluation of the Efficacy of a Full-Spectrum Low-THC Cannabis Plant Extract Using In Vitro Models of Inflammation and Excitotoxicity

As a library, NLM provides access to scientific literature. Inclusion in an NLM database does…

Freedom WaresNovember 11, 2024

Canna~Fangled Abstracts

Full-spectrum cannabidiol reduces UVB damage through the inhibition of TGF-β1 and the NLRP3 inflammasome

Photochem Photobiol. 2024 Jul 3. doi: 10.1111/php.13993. Online ahead of print. I M Urrutia-Ortega 1 2, I Valencia 2, O…

Freedom WaresJuly 3, 2024

Canna~Fangled Abstracts

Development, Characterization and In Vitro Gastrointestinal Release of PLGA Nanoparticles Loaded with Full-Spectrum Cannabis Extracts

AAPS PharmSciTech. 2024 May 30;25(5):120. doi: 10.1208/s12249-024-02836-4. Aitor Villate 1 2, Gastón Pablo Barreto 3 4, Markel San Nicolás 5 6 7, Oier Aizpurua-Olaizola 7, Maitane Olivares 5 6, Aresatz…

Freedom WaresMay 30, 2024

Canna~Fangled Abstracts

Medical Cannabinoids as Treatment for Hypophosphatasia-Related Symptoms

Case Reports Complement Med Res. 2022 Nov 15. doi: 10.1159/000528069. Online ahead of print. Jan…

Freedom WaresNovember 16, 2022

Canna~Fangled Abstracts

Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial

Journal List > Commun Med (Lond) > v.2; 2022 > PMC9628346 Commun Med (Lond). 2022; 2:…

Freedom WaresNovember 2, 2022

Canna~Fangled Abstracts

Optimal Treatment with Cannabis Extracts Formulations Is Gained via Knowledge of Their Terpene Content and via Enrichment with Specifically Selected Monoterpenes and Monoterpenoids

Molecules. 2022 Oct 15;27(20):6920. doi: 10.3390/molecules27206920. Noa Raz 1, Aharon M Eyal 1, Elyad M Davidson 2 Affiliations expand PMID: 36296511 DOI: 10.3390/molecules27206920…

Freedom WaresOctober 15, 2022

Canna~Fangled Abstracts

Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum, High-Cannabidiol Treatment in an Open-Label Clinical Trial

PDF Research Letter November 4, 2020 M. Kathryn Dahlgren, PhD1,2,3; Kelly A. Sagar, PhD1,2,3; Ashley M. Lambros, BS1,2; et alRosemary T. Smith, BS1,2; Staci A. Gruber, PhD1,2,3 Author Affiliations Article Information JAMA…

Freedom WaresNovember 4, 2020

Full-SpectruM

Evaluation of the Efficacy of a Full-Spectrum Low-THC Cannabis Plant Extract Using In Vitro Models of Inflammation and Excitotoxicity

Full-spectrum cannabidiol reduces UVB damage through the inhibition of TGF-β1 and the NLRP3 inflammasome

Development, Characterization and In Vitro Gastrointestinal Release of PLGA Nanoparticles Loaded with Full-Spectrum Cannabis Extracts

Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial

Optimal Treatment with Cannabis Extracts Formulations Is Gained via Knowledge of Their Terpene Content and via Enrichment with Specifically Selected Monoterpenes and Monoterpenoids

Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum, High-Cannabidiol Treatment in an Open-Label Clinical Trial

Recent Posts

Archives

Categories